Quarterly report pursuant to Section 13 or 15(d)

Condensed Statement of Operations

v2.3.0.15
Condensed Statement of Operations (USD $)
3 Months Ended 9 Months Ended 128 Months Ended
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Sep. 30, 2010
Sep. 30, 2011
Cumulative from March 19, 2001 (Inception) [Member]
Revenues:          
Research $ 0 $ 0 $ 0 $ 0  
Development Stage Enterprise, Cumulative Revenue         0
Expenses:          
General and administrative 774,307 1,561,377 2,811,097 4,423,376 26,610,263
Research and development 2,372,201 671,339 10,506,823 2,453,350 30,400,339
Patent fees 198,424 123,147 374,163 238,089 1,929,141
Depreciation and amortization 10,127 11,663 34,904 34,843 630,371
Total Expenses 3,355,059 2,367,526 13,726,987 7,149,658 59,570,114
Loss from Operations (3,355,059) (2,367,526) (13,726,987) (7,149,658) (59,570,114)
Other Income (Expense)          
Realized loss on marketable securities 0 0 (3,960) 0 (13,301)
Interest income 19,592 49,418 100,914 97,699 1,412,981
Interest expense 0 0 0 0 (301,147)
Other income 0 0 0 56,047 56,047
Unrealized gain (loss) on fair value of warrants 1,866,249 2,536,999 1,993,469 (4,333,496) 891,124
Unrealized gain on fair value of put feature on common stock 0 0 0 97,713 2,315,539
Financing expense 0 0 (97,667) (180,080) (640,023)
Beneficial conversion feature 0 0 0 0 (1,625,000)
Total Other Income (Expense) 1,885,841 2,586,417 1,992,756 (4,262,117) 2,096,220
Net (Loss) Income Before Provision for Income Taxes (1,469,218) 218,891 (11,734,231) (11,411,775) (57,473,894)
Provision for income taxes 0 0 0 0 0
Net (Loss) Income $ (1,469,218) $ 218,891 $ (11,734,231) $ (11,411,775) $ (57,473,894)
Net loss per share, basic and diluted $ (0.02) $ 0.00 $ (0.13) $ (0.15)  
Weighted average number of shares outstanding, basic and diluted 95,240,221 83,063,250 92,276,111 76,932,814